Search results
What Your Symptoms Can Tell You About Your Rheumatoid Arthritis
Health.com· 7 days agoRheumatoid arthritis (RA) is an autoimmune disorder that causes inflammation, pain, and stiffness in...
Top Stock Reports for Apple, Mastercard & Amgen
Zacks via Yahoo Finance· 3 days agoToday's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Mastercard (MA) and Amgen (AMGN), as well as two...
What to know about biologics for Crohn's disease
Medical News Today· 3 days agoCrohn’s disease biologics are medications created using components of living organisms. Crohn’s disease (CD), along with ulcerative colitis, is one of...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace via Yahoo Finance· 6 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
6 Safe Blue Chip Dividend Stocks That Yield More Than Treasury Bonds
247wallst.com· 6 days agoSince 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital ...
Robeco Institutional Asset Management B.V. Sells 180,219 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 2 days agoRobeco Institutional Asset Management B.V. trimmed its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 52.7% in the 4th quarter, according to its most recent 13F filing with the Securities ...
Maryland Drug Board Advances Ozempic, Other Cost Reviews (1)
Bloomberg Law· 6 days agoBlockbuster diabetes drugs Ozempic and Trulicity will be included in the Maryland prescription drug board’s first cost review, a monthslong process that will help the panel determine whether ...
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 7 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...